PT89193A - Processo para a preparacao de acidos aralifatil-aminoalcano-difosfonicos - Google Patents

Processo para a preparacao de acidos aralifatil-aminoalcano-difosfonicos

Info

Publication number
PT89193A
PT89193A PT89193A PT8919388A PT89193A PT 89193 A PT89193 A PT 89193A PT 89193 A PT89193 A PT 89193A PT 8919388 A PT8919388 A PT 8919388A PT 89193 A PT89193 A PT 89193A
Authority
PT
Portugal
Prior art keywords
denotes
aliphatic radical
aralifatil
aminoalcan
preparation
Prior art date
Application number
PT89193A
Other languages
English (en)
Other versions
PT89193B (pt
Inventor
Knut A Jaeggi
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of PT89193A publication Critical patent/PT89193A/pt
Publication of PT89193B publication Critical patent/PT89193B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/44Amides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/3873Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503Five-membered rings
    • C07F9/6506Five-membered rings having the nitrogen atoms in positions 1 and 3

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Steroid Compounds (AREA)
PT89193A 1987-12-11 1988-12-09 Processo para a preparacao de acidos aralifatil-aminoalcano-difosfonicos PT89193B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH484787 1987-12-11

Publications (2)

Publication Number Publication Date
PT89193A true PT89193A (pt) 1989-12-29
PT89193B PT89193B (pt) 1993-06-30

Family

ID=4283590

Family Applications (1)

Application Number Title Priority Date Filing Date
PT89193A PT89193B (pt) 1987-12-11 1988-12-09 Processo para a preparacao de acidos aralifatil-aminoalcano-difosfonicos

Country Status (21)

Country Link
EP (1) EP0320455B1 (pt)
JP (1) JPH01197495A (pt)
KR (1) KR890009956A (pt)
AT (1) ATE90353T1 (pt)
AU (1) AU609549B2 (pt)
CA (1) CA1329609C (pt)
DD (1) DD283631A5 (pt)
DE (1) DE3881659D1 (pt)
DK (1) DK688488A (pt)
ES (1) ES2054868T3 (pt)
FI (1) FI92704C (pt)
HU (1) HU202880B (pt)
IE (1) IE62738B1 (pt)
IL (1) IL88620A (pt)
MX (1) MX14109A (pt)
NO (1) NO176663C (pt)
NZ (1) NZ227273A (pt)
PH (1) PH26416A (pt)
PT (1) PT89193B (pt)
YU (1) YU221388A (pt)
ZA (1) ZA889157B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW198039B (pt) * 1988-11-28 1993-01-11 Ciba Geigy Ag
US5270365A (en) * 1991-12-17 1993-12-14 Merck & Co., Inc. Prevention and treatment of periodontal disease with alendronate
US5391743A (en) * 1992-05-29 1995-02-21 Procter & Gamble Pharmaceuticals, Inc. Quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism and methods of treating and preventing dental calculus and plaque
DK0642519T3 (da) * 1992-05-29 2000-09-18 Procter & Gamble Pharma Svovlholdige phosphonatforbindelser til behandling af unormal calcium- og phosphatmetabolisme
US5753634A (en) * 1992-05-29 1998-05-19 The Procter & Gamble Company Quaternary nitrogen containing phosphonate compounds, pharmaceutical compostions, and methods for treating abnormal calcium and phosphate metabolism
US5763611A (en) * 1992-05-29 1998-06-09 The Procter & Gamble Company Thio-substituted cyclic phosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
FI945595A7 (fi) * 1992-05-29 1994-11-28 Procter & Gamble Pharmaceuticals Inc Tiosubstituoituja typpipitoisia heterosyklisiä fosfonaattiyhdisteitä e pänormaalin kalsium- ja fosfaattiaineenvaihdunnan hoitamiseksi
EP0646119B1 (en) * 1992-05-29 1998-07-15 PROCTER & GAMBLE PHARMACEUTICALS, INC. Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism as well as dental calculus and plaque
DE69324684T2 (de) * 1992-06-30 1999-11-25 Procter & Gamble Pharmaceuticals, Inc. Arzneimitteln zur behandlung von arthritis die phosphonate und nsaids enthalten
WO2015095317A1 (en) * 2013-12-19 2015-06-25 3M Innovative Properties Company Articles comprising self-assembled layers comprising nanoparticles with a phosphorous surface treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27078A (en) * 1984-12-21 1993-02-01 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonates
IL77243A (en) * 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
DE3623397A1 (de) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
NO885489D0 (no) 1988-12-09
DK688488A (da) 1989-06-12
NO885489L (no) 1989-06-12
MX14109A (es) 1994-02-28
ATE90353T1 (de) 1993-06-15
DK688488D0 (da) 1988-12-09
FI885710A0 (fi) 1988-12-09
HU202880B (en) 1991-04-29
FI92704C (fi) 1994-12-27
NZ227273A (en) 1991-06-25
JPH01197495A (ja) 1989-08-09
PH26416A (en) 1992-07-15
IE883680L (en) 1989-06-11
IE62738B1 (en) 1995-02-22
FI885710A7 (fi) 1989-06-12
NO176663B (no) 1995-01-30
PT89193B (pt) 1993-06-30
DE3881659D1 (en) 1993-07-15
ES2054868T3 (es) 1994-08-16
FI92704B (fi) 1994-09-15
EP0320455A1 (de) 1989-06-14
CA1329609C (en) 1994-05-17
YU221388A (en) 1990-06-30
IL88620A (en) 1994-11-28
AU609549B2 (en) 1991-05-02
NO176663C (no) 1995-05-10
KR890009956A (ko) 1989-08-05
ZA889157B (en) 1989-07-26
EP0320455B1 (de) 1993-06-09
AU2673888A (en) 1989-06-15
IL88620A0 (en) 1989-07-31
HUT48899A (en) 1989-07-28
DD283631A5 (de) 1990-10-17

Similar Documents

Publication Publication Date Title
PT86165A (en) Process for the manufacture of aromatically substituted azacicloalkylalkanediphosphonis acids
PT89193A (pt) Processo para a preparacao de acidos aralifatil-aminoalcano-difosfonicos
PT92399A (pt) Processo para a preparacao de acidos fenilalifatilaminoalcano-difosfonicos
HUT45521A (en) Process for producing quinolinecarboxylic acid derivatives
DE69202062D1 (de) Verfahren zur Herstellung von Diphosphonsäuren und Salzen davon.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19921215

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19960630